Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Sep 30, 2025 | (FY)Sep 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 14.35%8.58B | 20.46%7.5B | 18.52%1.51B | 34.14%1.73B | 40.63%6.23B | 1.93B | 46.90%1.72B | 37.91%1.28B | 26.85%1.29B | 25.41%4.43B |
| Cost of revenue | 15.41%729.02M | 55.59%631.65M | 51.58%117.76M | 152.29%155.89M | 135.52%405.97M | 153.78M | 151.57%112.7M | 117.47%77.69M | 106.05%61.79M | 100.94%172.37M |
| Gross profit | 14.26%7.85B | 18.01%6.87B | 16.38%1.4B | 28.21%1.58B | 36.79%5.82B | 1.78B | 42.75%1.61B | 34.72%1.2B | 24.44%1.23B | 23.53%4.26B |
| Operating expense | 13.69%5.78B | 10.90%5.08B | 7.61%1.07B | 19.10%1.2B | 18.85%4.58B | 1.36B | 19.09%1.21B | 19.02%994.87M | 10.07%1.01B | -15.77%3.86B |
| Selling and administrative expenses | 13.80%5.87B | 12.76%5.16B | 11.63%1.12B | 19.57%1.22B | 18.40%4.58B | --1.36B | 17.75%1.2B | 18.44%999.34M | 10.44%1.02B | 4.15%3.87B |
| -General and administrative expense | 13.80%5.87B | 12.76%5.16B | 11.63%1.12B | 19.57%1.22B | 18.40%4.58B | --1.36B | 17.75%1.2B | 18.44%999.34M | 10.44%1.02B | 4.15%3.87B |
| Other operating expenses | -69.33%3.64M | -64.63%11.85M | -58.26%359K | -67.03%674K | 455.70%33.51M | --12.6M | 947.03%18.01M | 42,900.00%860K | 146.56%2.04M | -99.43%6.03M |
| Total other operating income | 8.78%100.48M | 217.08%92.37M | 751.12%45.39M | 52.10%13.77M | 70.36%29.13M | --9.94M | 135.36%4.81M | -32.31%5.33M | 124.17%9.05M | -91.43%17.1M |
| Operating profit | 15.86%2.07B | 44.27%1.79B | 59.08%325.05M | 70.01%374.43M | 209.03%1.24B | 418.93M | 263.50%397.37M | 276.63%204.33M | 210.68%220.24M | 135.51%401.53M |
| Net non-operating interest income (expenses) | -248.71%-1.91M | 124.35%1.28M | 9.51%-923K | 412.73%3.98M | 50.71%-5.27M | -1.37M | 30.02%-1.6M | 48.64%-1.02M | 72.68%-1.27M | 48.78%-10.69M |
| Non-operating interest income | -77.26%1.16M | 127,450.00%5.1M | 200.00%3K | --5.1M | -50.00%4K | --2K | 0.00%1K | -75.00%1K | --0 | -52.94%8K |
| Non-operating interest expense | -19.66%3.07M | -27.59%3.82M | -9.30%926K | -12.18%1.12M | -50.71%5.27M | --1.37M | -30.00%1.61M | -48.69%1.02M | -72.68%1.27M | -48.78%10.7M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 15.67%2.07B | 44.98%1.79B | 59.43%324.12M | 72.81%378.41M | 216.14%1.24B | 417.56M | 269.79%395.76M | 288.99%203.3M | 230.62%218.97M | 133.94%390.84M |
| Income tax | 103.43%633.69M | 403.96%311.5M | 97.44%-4.09M | 293.86%117.31M | -25.22%-102.48M | 179.12M | -1,277.52%-61.49M | -469,305.88%-159.6M | -18,928.93%-60.51M | -152.28%-81.84M |
| Net income | -2.80%1.44B | 10.60%1.48B | -9.56%328.21M | -6.58%261.1M | 183.08%1.34B | 238.44M | 349.16%457.25M | 593.89%362.9M | 319.96%279.48M | 142.23%472.68M |
| Net income continuous operations | -2.80%1.44B | 10.60%1.48B | -9.56%328.21M | -6.58%261.1M | 183.08%1.34B | --238.44M | 349.16%457.25M | 593.90%362.9M | 319.97%279.48M | 142.23%472.68M |
| Noncontrolling interests | 99.90%25.24M | 172.89%12.63M | 1.67M | 5.91M | -17.32M | -29.6M | 12.28M | 0 | 0 | 0 |
| Net income attributable to the company | -3.69%1.41B | 8.26%1.47B | -10.02%326.54M | -8.69%255.2M | 186.75%1.36B | 268.04M | 337.09%444.97M | 593.89%362.9M | 319.96%279.48M | 142.23%472.68M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -3.69%1.41B | 8.26%1.47B | -10.02%326.54M | -8.69%255.2M | 186.75%1.36B | 268.04M | 337.09%444.97M | 593.89%362.9M | 319.96%279.48M | 142.23%472.68M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -6.03%60.3 | 6.19%64.17 | -14.48%14.35 | -12.22%11.35 | 176.19%60.43 | 10.38 | 330.57%20.28 | 593.39%16.78 | 319.81%12.93 | 142.21%21.88 |
| Diluted earnings per share | -6.47%59.16 | 9.11%63.25 | -13.54%14.17 | -14.83%10.97 | 164.95%57.97 | 9.63 | 308.28%19.23 | 577.27%16.39 | 318.18%12.88 | 142.21%21.88 |
| Dividend per share | 166.67%40 | 15 | ||||||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |